In this episode of Biome Breakthroughs, we take a deep dive into the world of inflammatory bowel disease (IBD) with a special focus on ulcerative colitis (UC) and explore why fecal microbiota transplantation (FMT) is being called the next big breakthrough in gut health.

For many patients, standard treatments such as steroids, immunosuppressants, and biologics eventually lose their effectiveness or create difficult side effects. But growing research shows that FMT may provide another path forward.

💡 Inside this episode, you’ll learn:

• Why traditional drugs often stop working for UC and Crohn’s patients
• The latest research showing 20%–80% remission rates with FMT in UC
• How longer protocols, donor matching, and oral capsules are improving patient outcomes
• Why monitoring biomarkers like calprotectin and CRP can predict relapses before they happen
• How diet, lifestyle, stress, and sleep can either support or sabotage long-term remission
• A real patient story: a young man with severe UC who avoided surgery, came off biologic, and reached clinical remission after committing to a year-long FMT protocol
  

This episode is a must-listen for anyone struggling with ulcerative colitis, Crohn’s disease, or IBD as well as clinicians looking to better understand where FMT may fit into the future of treatment.

📩 Reach out at: [email protected]
🌐 Explore more at www.novelbiome.com
🎧 Subscribe to Biome Breakthroughs for more real conversations about gut science, microbiome medicine, and functional healing.